HeartBeam Announces Acquisition of LIVMOR Assets
Legacy MEDSearch
MARCH 15, 2023
Founded in 2016, LIVMOR developed the Halo+ Atrial Fibrillation (AF) Detection System, the world’s first FDA-cleared prescription wearable for continuous cardiac rhythm monitoring. The acquisition extends HeartBeam’s reach in remote monitoring and detection with full ownership of an existing cutting-edge FDA-cleared product.
Let's personalize your content